RXi Pharmaceuticals Corporation (RXII) fell -5.43% or -0.07 to $1.22. It is around 144928 shares traded, which is 179.08% compare to the average total volume 80931. The market cap of RXII is $5.34 million. The year to date change is -81.97%. The 52 week price range is from $1.18 to $7.7. Price of RXII have changed -11.03% during last week. It have changed -15.13% over last month, -42.67% over last 3 months, -76.07% over last 6 months and -74.43% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RXII is 1.63. It is 33.61% above current price. The 200-day Moving Averages for RXII is 3.09. It is 153.28% above current price. The 52-week High is 7.7. It is 531.15% from the current price. The 52-week Low is 1.18. It is -3.28% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RXII is 0.86 on 2018-08-31. Short % to float is 17.53%. There are some statistics of RXII. It is has market cap $5.34 million. The share outstanding is 4.38 million. The average volume is 80931. The percent of top 15 Institution holding is 32.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RXII is -184.47%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RXII is -117.95%.